Journal articleJAMA2013
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
- Journal
- JAMA
- Published
- 1 October 2013
- Citations
- 1,368
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 6
- BackgroundUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- BackgroundSplit-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer NCT04289792↗
- BackgroundMetronomic Chemotherapy With Capecitabine for Pancreatic Cancer NCT03959150↗
- BackgroundA Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX NCT03450018↗
- BackgroundSBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer NCT02704156↗